// App-Quantinova.ai

THU0175 : REAL-WORLD EXPERIENCE OF SWITCHING FROM ORIGINATOR TO BIOSIMILAR RITUXIMAB IN RHEUMATOID ARTHRITIS

Researchers

Presenter

  • A. Melville

Principal Investigators

  • M. Y. MD Yusof

  • J. Fitton

  • L. Bailey

  • P. Emery

  • M. H. Buch

  • S. Dass

  • B. Saleem

Medical Centers

  • University of Leeds, Leeds Institue of Rheumatic and Musculoskeletal Medicine, Leeds, United Kingdom

  • Leeds Teaching Hospitals NHS Trust, Rheumatology department, Leeds, United Kingdom

  • Univ of Manchester, Centre for Musculoskeletal Research, Manchester, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Rituximab

Outcome

  • N/A

Study Design

  • Observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Abbvie

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved